| 1 | [SID103479736] | Active | IC50 | 0.068 | Antiprotozoan activity against Trichomonas vaginalis GT3 trophozoites after 48 hrs [AID598282, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 0.068 [uM] | | BioAssay | Antiprotozoan activity against Trichomonas vaginalis GT3 trophozoites after 48 hrs | | AID | 598282 | | BioAssay type | Literature | | Target | | | PubMed | 21397502 | | Data Table |  |
|
| 2 | [SID103479736] | Active | EC50 | 0.12 | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as decrease in extracellular viral DNA measured 24 hrs after last dose [AID606883, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 0.12 [uM] | | BioAssay | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as decrease in extracellular viral DNA measured 24 hrs after last dose | | AID | 606883 | | BioAssay type | Literature | | Target | | | PubMed | 21553812 | | Data Table |  |
|
| 3 | [SID103479736] | Active | EC50 | 0.13 | Antiviral activity against HCV genotype 1a in replicon system [AID533311, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 0.13 [uM] | | BioAssay | Antiviral activity against HCV genotype 1a in replicon system | | AID | 533311 | | BioAssay type | Literature | | Target | | | PubMed | 18710916 | | Data Table |  |
|
| 4 | [SID103479736] | Active | EC50 | 0.16 | Antiviral activity against HCV genotype 1b in RP7 replicon cell after 4 days by blot hybridization analysis [AID533313, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 0.16 [uM] | | BioAssay | Antiviral activity against HCV genotype 1b in RP7 replicon cell after 4 days by blot hybridization analysis | | AID | 533313 | | BioAssay type | Literature | | Target | | | PubMed | 18710916 | | Data Table |  |
|
| 5 | [SID103479736] | Active | EC50 | 0.21 | Antiviral activity against HCV genotype 1b infected in Ava5 cells assessed as inhibition of viral replication after 3 days by blot hybridization analysis [AID642456, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 0.21 [uM] | | BioAssay | Antiviral activity against HCV genotype 1b infected in Ava5 cells assessed as inhibition of viral replication after 3 days by blot hybridization analysis | | AID | 642456 | | BioAssay type | Literature | | Target | | | PubMed | 22059983 | | Data Table |  |
|
| 6 | [SID103479736] | Active | Ki | 0.3 | Inhibition of Giardia lamblia recombinant nitroreductase 1 (EAA43030.1) expressed in Escherichia coli [AID325504, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | Ki | 0.3 [uM] | | BioAssay | Inhibition of Giardia lamblia recombinant nitroreductase 1 (EAA43030.1) expressed in Escherichia coli | | AID | 325504 | | BioAssay type | Literature | | Target | | | PubMed | 17438059 | | Data Table |  |
|
| 7 | [SID103479736] | Active | EC50 | 0.33 | Antiviral activity against HCV genotype 1a infected in Huh7.5 cells assessed as inhibition of viral replication after 3 days by blot hybridization analysis [AID642459, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 0.33 [uM] | | BioAssay | Antiviral activity against HCV genotype 1a infected in Huh7.5 cells assessed as inhibition of viral replication after 3 days by blot hybridization analysis | | AID | 642459 | | BioAssay type | Literature | | Target | | | PubMed | 22059983 | | Data Table |  |
|
| 8 | [SID26719875] | Active | Potency | 0.5012 | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 0.5012 [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 9 | [SID103479736] | Active | IC50 | 0.504 | Antiprotozoan activity against Entamoeba histolytica HM1-IMSS trophozoites after 48 hrs [AID598283, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 0.504 [uM] | | BioAssay | Antiprotozoan activity against Entamoeba histolytica HM1-IMSS trophozoites after 48 hrs | | AID | 598283 | | BioAssay type | Literature | | Target | | | PubMed | 21397502 | | Data Table |  |
|
| 10 | [SID103479736] | Active | EC50 | 0.59 | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as decrease in intracellular viral DNA measured 24 hrs after last dose [AID606884, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 0.59 [uM] | | BioAssay | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as decrease in intracellular viral DNA measured 24 hrs after last dose | | AID | 606884 | | BioAssay type | Literature | | Target | | | PubMed | 21553812 | | Data Table |  |
|
| 11 | [SID17388853] | Active | Potency | 0.7079 | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway [AID651777, Type: confirmatory] | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway | | AID | 651777 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] | | PubMed | | | Data Table |  |
|
| 12 | [SID17388853] | Active | Potency | 0.7079 | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway [AID651777, Type: confirmatory] | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway | | AID | 651777 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] | | PubMed | | | Data Table |  |
|
| 13 | [SID17388853] | Active | Potency | 0.7079 | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway [AID651777, Type: confirmatory] | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 0.7079 [uM] | | BioAssay | qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway | | AID | 651777 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor [Homo sapiens] [gi:51095037] | | PubMed | | | Data Table |  |
|
| 14 | [SID17388853] | Active | Potency | 0.7208 | Biochemical firefly luciferase enzyme assay for NPC [AID624030, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 0.7208 [uM] | | BioAssay | Biochemical firefly luciferase enzyme assay for NPC | | AID | 624030 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 15 | [SID103479736] | Active | MIC | 0.8 | Antimicrobial activity against Campylobacter jejuni [AID484859, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | MIC | 0.8 [uM] | | BioAssay | Antimicrobial activity against Campylobacter jejuni | | AID | 484859 | | BioAssay type | Literature | | Target | | | PubMed | 20488706 | | Data Table |  |
|
| 16 | [SID103479736] | Active | EC50 | 1.2 | Antiviral activity against HCV genotype 1b in NTZ-11 replicon cell after 4 days by blot hybridization analysis [AID533314, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 1.2 [uM] | | BioAssay | Antiviral activity against HCV genotype 1b in NTZ-11 replicon cell after 4 days by blot hybridization analysis | | AID | 533314 | | BioAssay type | Literature | | Target | | | PubMed | 18710916 | | Data Table |  |
|
| 17 | [SID103479736] | Active | IC50 | 1.214 | Antiprotozoan activity against Giardia intestinalis IMSS:0696:1 trophozoites after 48 hrs [AID598281, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 1.214 [uM] | | BioAssay | Antiprotozoan activity against Giardia intestinalis IMSS:0696:1 trophozoites after 48 hrs | | AID | 598281 | | BioAssay type | Literature | | Target | | | PubMed | 21397502 | | Data Table |  |
|
| 18 | [SID17388853] | Active | Potency | 1.2589 | qHTS Assay for Anthrax Lethal Toxin Internalization [AID912, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 1.2589 [uM] | | BioAssay | qHTS Assay for Anthrax Lethal Toxin Internalization | | AID | 912 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table |  |
|
| 19 | [SID103479736] | Active | EC50 | 1.5 | Antiviral activity against HCV genotype 1b in TIZ-9 replicon cell after 4 days by blot hybridization analysis [AID533315, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | EC50 | 1.5 [uM] | | BioAssay | Antiviral activity against HCV genotype 1b in TIZ-9 replicon cell after 4 days by blot hybridization analysis | | AID | 533315 | | BioAssay type | Literature | | Target | | | PubMed | 18710916 | | Data Table |  |
|
| 20 | [SID103479736] | Active | Ki | 2.2 | Inhibition of PFOR Trichomonas vaginalis [AID283185, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | Ki | 2.2 [uM] | | BioAssay | Inhibition of PFOR Trichomonas vaginalis | | AID | 283185 | | BioAssay type | Literature | | Target | | | PubMed | 17158936 | | Data Table |  |
|
| 21 | [SID26719875] | Active | Potency | 3.1623 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 22 | [SID26719875] | Active | Potency | 3.1623 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 23 | [SID103479736] | Active | IC50 | 3.25 | Antiparasitic activity against Cryptosporidium parvum in HCT8 cells [AID260527, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 3.25 [uM] | | BioAssay | Antiparasitic activity against Cryptosporidium parvum in HCT8 cells | | AID | 260527 | | BioAssay type | Literature | | Target | | | PubMed | 16480281 | | Data Table |  |
|
| 24 | [SID103479736] | Active | IC50 | 3.8 | Antimicrobial activity against Cryptosporidium parvum infected in human HCT-8 cells [AID572366, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 3.8 [uM] | | BioAssay | Antimicrobial activity against Cryptosporidium parvum infected in human HCT-8 cells | | AID | 572366 | | BioAssay type | Literature | | Target | | | PubMed | 18591280 | | Data Table |  |
|
| 25 | [SID103479736] | Active | IC50 | 3.89 | Antimalarial activity against Plasmodium berghei schizonts isolated from parasitized erythrocytes infected Wistar rat measured 16 hrs post compound exposure [AID598286, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 3.89 [uM] | | BioAssay | Antimalarial activity against Plasmodium berghei schizonts isolated from parasitized erythrocytes infected Wistar rat measured 16 hrs post compound exposure | | AID | 598286 | | BioAssay type | Literature | | Target | | | PubMed | 21397502 | | Data Table |  |
|
| 26 | [SID103479736] | Active | Ki | 4.5 | Inhibition of PFOR Helicobacter pylori [AID283187, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | Ki | 4.5 [uM] | | BioAssay | Inhibition of PFOR Helicobacter pylori | | AID | 283187 | | BioAssay type | Literature | | Target | | | PubMed | 17158936 | | Data Table |  |
|
| 27 | [SID103479736] | Active | IC50 | 6.18 | Antileishmanial activity against Leishmania mexicana MHOM/MX/ISETGS promastigotes after 72 hrs by neubauer chamber [AID598284, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 6.18 [uM] | | BioAssay | Antileishmanial activity against Leishmania mexicana MHOM/MX/ISETGS promastigotes after 72 hrs by neubauer chamber | | AID | 598284 | | BioAssay type | Literature | | Target | | | PubMed | 21397502 | | Data Table |  |
|
| 28 | [SID17388853] | Active | Potency | 6.6824 | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay [AID651755, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 6.6824 [uM] | | BioAssay | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay | | AID | 651755 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID26719875] | Active | Potency | 6.7456 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 30 | [SID17388853] | Active | Potency | 7.4978 | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay [AID651754, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 7.4978 [uM] | | BioAssay | qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay | | AID | 651754 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID17388853] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 | | AID | 884 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 32 | [SID17388853] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 | | AID | 884 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 33 | [SID17388853] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 [AID884, Type: confirmatory] | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4 | | AID | 884 | | BioAssay type | confirmatory | | Target | cytochrome P450, family 3, subfamily A, polypeptide 4 [Homo sapiens] [gi:13435386] | | PubMed | | | Data Table |  |
|
| 34 | [SID103479736] | Active | Ki | 10 | Inhibition of PFOR Entamoeba histolytica [AID283186, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | Ki | 10 [uM] | | BioAssay | Inhibition of PFOR Entamoeba histolytica | | AID | 283186 | | BioAssay type | Literature | | Target | | | PubMed | 17158936 | | Data Table |  |
|
| 35 | [SID103479736] | Active | Ki | 10.5 | Inhibition of PFOR Campylobacter jejuni [AID283188, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | Ki | 10.5 [uM] | | BioAssay | Inhibition of PFOR Campylobacter jejuni | | AID | 283188 | | BioAssay type | Literature | | Target | | | PubMed | 17158936 | | Data Table |  |
|
| 36 | [SID26719875] | Active | Potency | 11.2202 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 37 | [SID26719875] | Active | Potency | 11.2202 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 38 | [SID26719875] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 39 | [SID17388853] | Active | Potency | 12.5893 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 40 | [SID17388853] | Active | Potency | 12.5893 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 41 | [SID17388853] | Active | Potency | 12.5893 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 42 | [SID17388853] | Active | Potency | 12.5893 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 43 | [SID17388853] | Active | Potency | 12.5893 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 44 | [SID17388853] | Active | Potency | 12.5893 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 45 | [SID17388853] | Active | Potency | 12.5893 | Cell Viability - LYMP1-003 - Assay at 40 hr [AID964, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17388853 | | CID | 41684 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP1-003 - Assay at 40 hr | | AID | 964 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID103479736] | Active | MIC | 13 | Antimicrobial activity against Helicobacter pylori [AID484858, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | MIC | 13 [uM] | | BioAssay | Antimicrobial activity against Helicobacter pylori | | AID | 484858 | | BioAssay type | Literature | | Target | | | PubMed | 20488706 | | Data Table |  |
|
| 47 | [SID26719875] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 48 | [SID26719875] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 49 | [SID26719875] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase [AID1634, Type: confirmatory] | PKM gene product [Homo sapiens] [gi:33286418] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26719875 | | CID | 41684 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase | | AID | 1634 | | BioAssay type | confirmatory | | Target | PKM gene product [Homo sapiens] [gi:33286418] | | PubMed | | | Data Table |  |
|
| 50 | [SID103479736] | Active | IC50 | 18.73 | Antitrypanosomal activity against Trypanosoma cruzi MHOM/MX/1994/Ninoa epimastigotes after 72 hrs by neubauer chamber [AID598285, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103479736 | | CID | 41684 | | Outcome | Active | | IC50 | 18.73 [uM] | | BioAssay | Antitrypanosomal activity against Trypanosoma cruzi MHOM/MX/1994/Ninoa epimastigotes after 72 hrs by neubauer chamber | | AID | 598285 | | BioAssay type | Literature | | Target | | | PubMed | 21397502 | | Data Table |  |
|